Your browser doesn't support javascript.
loading
Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: A multicenter retrospective pilot study.
Chen, I-Chih; Lee, Cheng-Han; Fang, Ching-Chang; Chao, Ting-Hsing; Cheng, Ching-Lan; Chen, Yi; Yu, Ching-Lung; Lin, Chih-Chan; Lin, Chun-Yuan; Li, Yi-Heng.
Affiliation
  • Chen IC; Division of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan, ROC.
  • Lee CH; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan, ROC; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Fang CC; Division of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan, ROC.
  • Chao TH; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan, ROC. Electronic address: chaoth@mail.ncku.edu.tw.
  • Cheng CL; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Chen Y; Division of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan, ROC.
  • Yu CL; Division of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan, ROC.
  • Lin CC; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan, ROC.
  • Lin CY; Division of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan, ROC.
  • Li YH; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan, ROC.
J Chin Med Assoc ; 79(10): 521-30, 2016 Oct.
Article in En | MEDLINE | ID: mdl-27339180
BACKGROUND: The efficacy and safety of ticagrelor compared with clopidogrel in acute coronary syndrome has not previously been evaluated in an Eastern Asian population, which is recognized to have a different response to P2Y12 antagonists compared with the Caucasian population in real-life situations. METHODS: A multicenter retrospective pilot study was performed to evaluate 928 consecutive patients with acute coronary syndrome, receiving aspirin and one P2Y12 antagonist (324 ticagrelor or 604 clopidogrel). Using propensity score matching, 448 patients were selected and divided into two equal groups. Kaplan-Meier analysis was used to study patient survival and event-free status using the log-rank test. Independent covariates were identified using univariate in a multivariate Cox proportional hazard model. RESULTS: In the overall cohort, significant differences were observed for certain variables between the two groups. During the mean 164.3 (±116.4)-day follow-up in the overall cohort, ticagrelor treatment had no significant effect on the primary efficacy endpoint (myocardial infarction, stroke, or vascular death); however, in the matched cohort, ticagrelor showed a lower incidence of primary endpoint (hazard ratio: 0.56; 95% confidence interval: 0.30-1.04; p = 0.07) and stroke (hazard ratio: 0.15; 95% confidence interval: 0.02-1.24; p = 0.08) with marginal statistical significance, and a similar bleeding rate. The protective effect of ticagrelor treatment was consistent for all subgroups. More patients treated with ticagrelor experienced dyspnea (21.0% vs. 11.6%, p = 0.007), and P2Y12 antagonist treatment was consequently discontinued. CONCLUSION: Ticagrelor treatment could provide a marginally favorable effect at the expense of an increased risk of dyspnea in real-life situations. This pilot study provides a scientific basis to call for a larger, suitably powered Phase 4 prospective or observational study in this ethnic population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ticlopidine / Platelet Aggregation Inhibitors / Adenosine / Acute Coronary Syndrome / Purinergic P2Y Receptor Antagonists Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Chin Med Assoc Journal subject: MEDICINA Year: 2016 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ticlopidine / Platelet Aggregation Inhibitors / Adenosine / Acute Coronary Syndrome / Purinergic P2Y Receptor Antagonists Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Chin Med Assoc Journal subject: MEDICINA Year: 2016 Document type: Article Country of publication: Netherlands